Peyman Sardari Nia


Peyman Sardari Nia Peyman Sardari Nia, MD, PhD, is a Senior Consultant Cardiothoracic Surgeon in the department of cardiothoracic surgery at Maastricht University Medical Center, the Netherlands, where he specializes in minimally invasive cardiothoracic surgery. He is also the lead and instigator of mitral valve program in Maastricht. Dr Sardari Nia earned his MD and his PhD from University Antwerp, Belgium, and underwent residency training in general surgery in the same city. Dr Sardari Nia was awarded the Pfizer educational prize in 2009: this prize is bestowed by the University of Antwerp on one young specialist for excellence in clinical, scientific, and surgical qualities during his or her whole residency across all the surgical specialties.  Following his residency in general surgery, Dr Sardari Nia underwent a fellowship training in cardiothoracic surgery at St Antonius Hospital in Nieuwegein, the Netherlands. He is board-certified in general and cardiothoracic surgery in Belgium and Netherlands.

Dr Sardari Nia’s PhD research focused on prognostic factors of lung metastases and non-small cell lung cancer, particularly how tumor growth patterns can inform post-surgical outcomes. He has received multiple awards for his research, notably the American Association of Cancer Research scholar-in-training award and European Association for Cardio-Thoracic Surgery (EACTS) Young Investigator award.

Dr Sardari Nia is an all-around cardiothoracic surgeon with special interest in surgery for mitral, lung cancer and minimally invasive adult cardiac surgery, especially endoscopic mitral valve repair, beating-heart mitral valve repair and VATS lobectomy. Over 90% of his procedures are done fully endoscopically with 3D vision. The focus of his academic and clinical activities is smart tailor-made surgery in which one selects, plans and performs interventions with mathematical precision with use of new technologies. He is an inventor and pioneer in surgical simulation, 3D printing and training of endoscopic mitral valve repair. He received the EACTS Techno-College Innovation Award for his invention of the high-fidelity endoscopic mitral valve surgery simulator 2014.

In addition to introducing and innovating minimally invasive approaches at his home institution, he is the founder and director of the EACTS courses in minimally invasive techniques for adult cardiac surgery and endoscopic mitral valve repair. He has been the program director of over 50 courses in minimally invasive cardiothoracic surgery, especially for mitral and has trained more than 300 surgeons from all the over world. He has given over 100 invited lectures worldwide and helped many centers starting the minimally invasive program. He is regularly consulted for complex mitral patients and operates patients referred to him also from other countries. He has been an EACTS councilor and a member of various EACTS committees since 2008. He is an associate editor of European Journal of Cardio-Thoracic Surgery (EJCTS) and an active member of the major cardiothoracic societies EACTS, AATS and STS. He was recently appointed as Editor-in-Chief of ICVTS and will assume this position from November 2020.